9 
8.0 
Study Parameters 
8.1 
Pretreatment Evaluation 
8.2 
Follow-up Procedures 
8.3 
Termination of Study 
9.0 
Evaluation Criteria 
9.1 
Adverse Drug Reaction Reporting 
9.2 
Response Criteria 
10.0 
Data Submission 
11.0 
Bibliography 
12.0 
Appendices 
12.1 
Toxicity and Complications Criteria 
12.2 
Karnofsky Performance Status 
12.3 
Data Forms 
12.4 
Patient Informed Consent Form 
12.5 
Laboratory Procedures and Safety Testing 
12.6 
Pre-Clinical Studies 
12.7 
Vector Description 
12.8 
Curriculum Vitae 
10 
12 
12 
14 
[632] 
Recombinant DNA Research, Volume 18 
